Roger Pomerantz

Companies

• EnlivexBoard member Mar 18, 2026 to now¹
• Indaptus Therapeutics, Inc.Board member Aug 2, 2021 to now²
• Viracta Therapeutics, Inc.Board member Feb 24, 2021 to Nov 27, 2024³
• CONTRAFECT CorpChief executive officer Apr 4, 2019 to Feb 17, 2022⁴
• CONTRAFECT CorpBoard member Jul 29, 2014 to Feb 17, 2022⁵
• Seres Therapeutics, Inc.Board member Jun 25, 2015 to Jun 14, 2019⁶
• Seres Therapeutics, Inc.Chief executive officer Jun 25, 2015 to Sep 11, 2018⁶
• Seres Therapeutics, Inc.President Jun 25, 2015 to Sep 11, 2018⁶
• Rubius Therapeutics (United States)Board member Jul 17, 2018 to Jul 23, 2018⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Enlivex ENLV2,480 shares⁸$489 at $0.20Mar 18, 2026
• VTViracta Therapeutics, Inc.126,478 shares⁹Nov 25, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 25, 2024Exercised options 9,034 shares of Viracta Therapeutics, Inc.⁹
• Aug 25, 2024Exercised options 9,034 shares of Viracta Therapeutics, Inc.¹⁰
• May 25, 2024Exercised options 9,035 shares of Viracta Therapeutics, Inc.¹¹
• Feb 25, 2024Exercised options 9,034 shares of Viracta Therapeutics, Inc.¹²
• Nov 25, 2023Exercised options 9,034 shares of Viracta Therapeutics, Inc.¹³
• Aug 25, 2023Exercised options 9,034 shares of Viracta Therapeutics, Inc.¹⁴
• May 25, 2023Exercised options 9,035 shares of Viracta Therapeutics, Inc.¹⁵
• Feb 25, 2023Exercised options 9,034 shares of Viracta Therapeutics, Inc.¹⁶
• Nov 25, 2022Exercised options 9,034 shares of Viracta Therapeutics, Inc.¹⁷
• Aug 25, 2022Exercised options 9,034 shares of Viracta Therapeutics, Inc.¹⁸
• May 25, 2022Exercised options 9,034 shares of Viracta Therapeutics, Inc.¹⁹
• Feb 25, 2022Exercised options 9,034 shares of Viracta Therapeutics, Inc.²⁰
• Nov 25, 2021Exercised options 18,068 shares of Viracta Therapeutics, Inc.²¹